![Daniel Palmacci](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 879 730 $ as of 2026-07-30
Daniel Palmacci is currently the President-Lonzas Cell & Gene Division at MorphoSys AG.
He started this position in 2022.
Prior to his current role, he graduated from Humboldt-Universität zu Berlin.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Lonza Group AG
 Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients 0% | 2025-12-30 | 1,266 ( 0% ) | 879 730 $ | 2026-07-30 |
| Companies | Position | End |
|---|---|---|
| MORPHOSYS AG | Chief Tech/Sci/R&D Officer | 2022-10-31 |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
